MedicosBiotech has been recognized at CES 2025 as the winner of the prestigious Digital Health Innovation Award, highlighting its revolutionary solution for chronic wound care, Cure Silk. This award underscores the company’s excellence in technology, design, and innovation, marking a milestone in wound care through the integration of Artificial Intelligence (AI) and advanced biotechnology.
Cure Silk: Innovation in Chronic Wound Care
Cure Silk combines advanced AI with therapeutic patches made from spider silk protein, providing a unique approach to treating chronic wounds. The solution includes a mobile app, Cure Silk App, which allows users to capture images of their wounds using a smartphone camera. Through AI-driven diagnostics, the app analyzes the type and severity of the wound, offering personalized treatment recommendations.
This technology, accessible even to those without medical experience, allows for effective wound management at home. It is particularly effective for treating Stage 3–4 pressure ulcers and Grade 5–6 diabetic ulcers, conditions that have challenged traditional treatment methods.
The Transformative Role of Spider Silk Protein
The core of Cure Silk is its therapeutic patch made from spider silk protein, a material known for its strength, elasticity, and biocompatibility. Although historically used in wound care for over 2,000 years, large-scale production has been a challenge until now. Advances in synthetic biology at MedicosBiotech have allowed for overcoming these barriers, maximizing the potential of this sustainable and effective material.
The Class II medical device approval from the Ministry of Food and Drug Safety of South Korea (MFDS) is expected in early 2025, paving the way for its global commercialization.
Accessibility and Transformation in Global Health
According to Soon Cheol Daniel Kim, COO of MedicosBiotech: “This award recognizes our innovative fusion of AI and biotechnology. Cure Silk is not only an accessible and affordable solution, but it also enhances access to chronic wound care, contributing to a more inclusive healthcare system.”
MedicosBiotech: Leading Biotechnological Innovation
In addition to Cure Silk, MedicosBiotech positions itself as a leader in sustainable, bio-based solutions for health and personal care. Its key innovations include:
- MCB-WH: A fast-acting wound healer.
- MCB-Graft: A solution for hair prevention and regeneration.
- MCB-SpiderSilk: Vegan and eco-friendly spider silk for medical and skincare applications.
Through these technologies, the company aims to transform health and beauty with innovative, safe, and effective solutions.
MedicosBiotech has demonstrated how the combination of AI and biotechnology can transform not only wound care but also the future of global health.